NKTR-262

· Nektar Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NKTR-262, covering 2023-03-08 to 2023-03-08. Get the full timeline:

Most recent: Clinical Trial Update: REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]

See pricing